ME/CFS after COVID

 I’ve been suffering from myalgic encephalomyelitis for over a year now (long covid or not, I don’t know), in an almost severe state for the last 6 months.

I recently had a Biomesight test and a long covid friend told me that you might be able to help me interpret my results.

Overview

Our usual first look visuals shows the dysbiosis and the typical pattern for ME/CFS and long COVID – an over abundance of bacteria at a low levels.

The forecast symptoms matches ME/CFS and Long COVID patterns

  1.  83.3 % match for Neurological-Sleep: Inability for deep (delta) sleep on 42 taxa
  2.  76.3 % match for Immune Manifestations: Hair loss on 38 taxa
  3.  76.3 % match for Immune Manifestations: Mucus in the stool on 93 taxa
  4.  75.2 % match for Neurocognitive: Problems remembering things on 141 taxa
  5.  74.7 % match for Neurocognitive: Absent-mindedness or forgetfulness on 162 taxa
  6.  74.6 % match for Neurological: Short-term memory issues on 71 taxa
  7.  74.5 % match for Neuroendocrine Manifestations: cold extremities on 55 taxa
  8.  74.3 % match for Neurocognitive: Can only focus on one thing at a time on 101 taxa

Drilling down into Health Predictors we see a rather high number, 13 items flagged. Looking at Dr. Jason Hawrelak Recommendations , we are at the 9%ile, not good.

Looking at Bacteria deemed unhealthy, we see the following very significant items.

  • Bilophila genus 100%ile High Level Cause Brain Fog(Cognitive impairment) Citation

Addressing the problem

The process is simple, just click this buttom

Then use the filtering button to view different suggestions. The highest priority was 1000, lowest -765 so we will look to take items over 500 and aggressively avoid items below -350. The dosages come from this summary page that links to studies, dosages should be reviewed by your MD before starting.

The avoid list is often ignored by people. They should not be. These items feed the undesired shifts.

Try for 8 weeks, then retest

While waiting for test results, keep to the suggestions.

  • As is common with ME/CFS people, you may want to be done with the disease ASAP so much you toss yourself into it. I have been there and done that. Taking everything at once risk major herx reaction. The key isĀ rotate and pulse.Ā Avoid substances that cause herx that is longer than 6 hours — you are not ready for those,Ā we need to take the longer pathĀ instead of trying to climbĀ a cliff face.
  • Try this pattern:
    • Take the probiotics, herbs and non-vitamin supplements into groups.
      • Week 1: take the probiotic for a week (#1 in priority)
      • Week 2: take one herb for a week (#1 in priority)
      • Week 3: one supplement for a week (#1 in priority)
      • Then go back to probiotic BUT take a different one (i.e. #2 in priority), same pattern for other things
    • After 8-12 weeks do a retest and see where suggestions have shifted
    • The goal is to destabilize a stable dysbiosis. In one sense, we want to do a guerilla war against it, not form up into a line and attempt march to frontal assault.

Questions and Answers

  • Do you know if my ME is due to the covid with these results?
    • It is impossible to tell from the microbiome. COVID could make an existing case of ME/CFS worse. If you were fine prior, then it is likely that COVID causes ME (i.e. Long COVID). Over time the dysbiosis between ME/CFS and Long COVID become very similar.
  • I’m allergic to penicillin (amoxycillin, etc.). What antibiotics can I take without it?
    • The best antibiotics that have been used by ME/CFS specialist were computed to be:
      • chloroquine diphosphate — anti-malarial and anti-rheumatoid agent and belongs to the drug class 4-aminoquinoline
      • dapsone – a sulfone, It works by decreasing swelling (inflammation) and stopping the growth of bacteria
      • neomycin – Ā belongs to theĀ aminoglycosides groupĀ of antibiotics
      • metronidazole – belongs to the nitroimidazoleĀ antimicrobials. MetronidazoleĀ is one of the mainstay drugs for the treatment of anaerobic bacterial infections, protozoal infections,Ā 
      • lymecycline – Ā tetracycline antibiotics.
    • My own preference would be to start with a tetracycline (lymecycline), followed by metronidazole, and then neomycin. This is largely based on the frequency of use that I have seen in the literature. At that point you should be retested.
      • I would follow Jadin’s pattern: 1 week on, 3 weeks off and then rotate to the next antibiotic.

Postscript – and Reminder

I am not a licensed medical professional and there are strict laws where I live about ā€œappearing to practice medicineā€.  I am safe when it is ā€œacademic modelsā€ and I keep to the language of science, especially statistics. I am not safe when the explanations have possible overtones of advising a patient instead of presenting data to be evaluated by a medical professional before implementing.

I can compute items to take, those computations do not provide information on rotations etc.

I cannot tell people what they should take or not take. I can inform people items that have better odds of improving their microbiome as a results on numeric calculations. I am a trained experienced statistician with appropriate degrees and professional memberships. All suggestions should be reviewed by your medical professional before starting.

The answers above describe my logic and thinking and is not intended to give advice to this person or any one. Always review with your knowledgeable medical professional.

ME/CFS after giving birth

Back Story

We would really like to take you up on your offer to make a youtube video (anonymous) to analyze my gut test results (OMBRE). We took a first pass on the website and found some interesting results but are a little overwhelmed at the suggestions. For reference, I have chronic fatigue after mostly recovering from POTS via the GAPS diet. This all started after giving birth. I attached the CSV from OMBRE in hopes that you are willing to help us out with this!

I understand well, my own wife developed ME/CFS also after giving birth.

Analysis

Her percentages of percentiles does not show the typical ME/CFS pattern which appears consistent with improvements from the GAPS diet.

Looking at General Health Predictors we have 17 predictors that are looking bad. Anti inflammatory Bacteria Score is 30%ile so inflammation is likely an issue

Going Forward

This person has entered their symptoms so we go with

Then use the filtering button to view different suggestions. The highest priority was 643, lowest -1014 (but 500 is where the list starts) so we will look to take items over 300 and aggressively avoid items below -250. The dosages come from this summary page that links to studies, dosages should be reviewed by your MD before starting.

Antibiotics

Usually these are not an option. But the suggested ones that are used by ME/CFS specialist are shown below

Avoids

Try for 8 weeks, then retest

While waiting for test results, keep to the suggestions.

Questions And Answers

  • When I got the list of suggestions, I started them all at once and herxed terribly. So much that I has to stop!
    • As is common with ME/CFS people, you want to be done with the disease so much you toss yourself into it. I have been there and done that. The key is rotate and pulse. Avoid substances that cause herx that is longer than 6 hours — you are not ready for those, we need to take the longer path instead of trying to climb a cliff face.
    • Try this pattern:
      • Take the probiotics, herbs and non-vitamin supplements into groups.
        • Week 1: take the probiotic for a week (#1 in priority)
        • Week 2: take one herb for a week (#1 in priority)
        • Week 3: one supplement for a week (#1 in priority)
        • Then go back to probiotic BUT take a different one (i.e. #2 in priority), same pattern for other things
      • After 8-12 weeks do a retest and see where suggestions have shifted
      • The goal is to destabilize a stable dysbiosis. In one sense, we want to do a guerilla war against it, not form up into a line and attempt march to frontal assault.
  • You mentioned my patterns are inconsistent with people with CFS yet the suggestions are very consistent with people with CFS. Does this mean my patterns are less severe or is this wishful thinking?
    • Compared to the sample that I shared with you, less severe is my guess. You have less severe dysbiosis. ME/CFS has a wide variety of symptoms; each have great variability.
  • I’m wondering if you think I should pursue the antibiotic route or if you think this should be last resort? Many people take garlic extract as a natural alternative to antibiotics. Do you think this might help/hurt?
  • You mentioned I have several pathogenic bacteria. What’s the best way to get rid of them? Is there a targeted antibiotic? 
  • You mentioned the general health predictors show 17 that are looking bad. Could you elaborate a bit on this?

Postscript – and Reminder

I am not a licensed medical professional and there are strict laws where I live about ā€œappearing to practice medicineā€.  I am safe when it is ā€œacademic modelsā€ and I keep to the language of science, especially statistics. I am not safe when the explanations have possible overtones of advising a patient instead of presenting data to be evaluated by a medical professional before implementing.

I can compute items to take, those computations do not provide information on rotations etc.

I cannot tell people what they should take or not take. I can inform people items that have better odds of improving their microbiome as a results on numeric calculations. I am a trained experienced statistician with appropriate degrees and professional memberships. All suggestions should be reviewed by your medical professional before starting.

The answers above describe my logic and thinking and is not intended to give advice to this person or any one. Always review with your knowledgeable medical professional.

Symptoms with Ability to Predict from Microbiome Results

The table below is based on Biomesight samples which has been annotated with self-reporting symptoms. A factor of 16 means no ability to predict.

  • A value of 20 indicates about a 56% chance of correctly predicting both With and Without
  • A value of 25 indicates about a 66% chance of correctly predicting both With and Without
  • A value of 30 indicates about a 70% chance of correctly predicting both With and Without

The chance can increase significantly (90+%) when you are willing to have a higher percentage of false positive.

The Table

Symptom NameFactor
Neurological-Sleep: Sleep Apnea30.42
Comorbid: Sugars cause sleep or cognitive issues29.39
Comorbid: Panic Attacks29.30
Comorbid: Carbohydrate intolerance28.89
Official Diagnosis: Hypercholesterolemia (High Cholesterol)28.51
DePaul University Fatigue Questionnaire : Fever & Chills28.14
Neurological: Disorientation27.99
Comorbid: Sleep Apnea Diagnosis27.83
Comorbid: Salicylate sensitive27.49
Pain: Eye pain27.46
Neurological: Seasonal Affective Disorder (SAD)27.39
Comorbid-Mouth: Gingivits / Gum Disease27.31
Condition: Generalized anxiety disorder27.21
Condition: Post-Traumatic Stress Disorder27.09
DePaul University Fatigue Questionnaire : Night sweats27.05
Neurological-Sleep: Night Sweats26.96
Autonomic Manifestations: exertional dyspnea26.96
Comorbid: Constipation and Explosions (not diarrohea)26.46
Autonomic Manifestations: cardiac arrhythmias26.39
Neurological-Sleep: Vivid Dreams/Nightmares26.39
Autism: High Functioning26.32
DePaul University Fatigue Questionnaire : Tense muscles26.27
Infection: Lyme26.26
Comorbid: Mold Sensitivity / Exposure26.26
Autonomic Manifestations: Cortisol disorders or irregularity26.22
Onset: less than 32 years since onset26.14
DePaul University Fatigue Questionnaire : Frequently get words or numbers in the wrong order26.05
Pain: Sensitivity to pain26.02
Blood Type: B Positive25.99
Other: Sensitivity to vibrations25.97
Autonomic Manifestations: bladder dysfunction25.96
Joint: Stiffness and swelling25.95
Comorbid: Raynaud’s syndrome (Skin discoloration)25.93
DePaul University Fatigue Questionnaire : Confusion/disorientation25.87
DePaul University Fatigue Questionnaire : New trouble with math25.87
Immune Manifestations: Thick blood / Hypercoagulation25.82
DePaul University Fatigue Questionnaire : Concern with driving25.82
DePaul University Fatigue Questionnaire : Weight change25.79
Pain: Myofascial pain25.77
Comorbid-Mouth: Mouth Sores25.76
DePaul University Fatigue Questionnaire : Chilled or shivery25.74
Official Diagnosis: Fibromyalgia25.73
Neuroendocrine: Feeling like you have a high temperature25.65
Neurological-Sleep: Chaotic diurnal sleep rhythms (Erratic Sleep)25.54
Neuroendocrine Manifestations: Excessive adrenaline25.52
Neurological: fasciculations25.50
Age: 60-7025.48
Autonomic: Inability to tolerate an upright position25.39
Comorbid: Mood Swings25.38
Comorbid: Inflammatory bowel disease25.37
Autonomic Manifestations: urinary frequency dysfunction25.32
Autonomic: Dizziness or fainting25.31
DePaul University Fatigue Questionnaire : Depression25.30
Neuroendocrine: Temperature fluctuations throughout the day25.29
Comorbid: Restless Leg25.29
Comorbid: Snoring (NOT Sleep Apnea25.29
DePaul University Fatigue Questionnaire : Nausea25.28
Official Diagnosis: Attention deficit hyperactivity disorder (ADHD)25.24
DePaul University Fatigue Questionnaire : Feeling like you have a temperature25.22
Infection: Human Herpesvirus 6 (HHV6)25.22
Neurological: High degree of Empathy before onset25.21
DePaul University Fatigue Questionnaire : Chemical sensitivity25.19
DePaul University Fatigue Questionnaire : Sore Throat25.17
Neuroendocrine Manifestations: abnormal appetite25.17
General: Anhedonia (inability to feel pleasure)25.13
Neurological-Vision: Blurred Vision25.09
Neurological-Vision: photophobia (Light Sensitivity)25.02
Immune Manifestations: tender lymph nodes24.97
DePaul University Fatigue Questionnaire : Upset stomach24.95
Pain: Aching of the eyes or behind the eyes24.86
Neurological: Confusion24.86
Neuroendocrine Manifestations: marked weight change24.83
DePaul University Fatigue Questionnaire : Dizziness24.74
Neuroendocrine Manifestations: subnormal body temperature24.68
DePaul University Fatigue Questionnaire : Racing heart24.64
Immune: Tender / sore lymph nodes24.62
Comorbid: Fibromyalgia24.58
Comorbid: Migraine24.54
General: Myalgia (pain)24.54
Neurocognitive: Feeling disoriented24.51
Official Diagnosis: Depression24.34
Neurocognitive: Unable to focus vision and/or attention24.34
Neurological: Neuropathy24.34
DePaul University Fatigue Questionnaire : Abnormal sensitivity to light24.32
Physical: Good Air Quality24.27
Official Diagnosis: Gastroesophageal reflux disease (GERD)24.27
Joint: Tenderness24.26
Physical: Tonsils removed24.24
Comorbid: Methylation issues (MTHFR)24.23
DePaul University Fatigue Questionnaire : Tingling feeling24.20
Other: Sensitivity to mold24.17
Neurological: emotional overload24.17
Official Diagnosis: COVID19 (Fully Recovered)24.15
Comorbid-Mouth: Dry Mouth24.13
Physical: Steps Per Day 8000-1600024.12
Autonomic: Shortness of breath24.04
Neuroendocrine: Lack of appetite24.03
DePaul University Fatigue Questionnaire : Slow to react23.99
Neuroendocrine Manifestations: loss of adaptability23.93
DePaul University Fatigue Questionnaire : Rash23.90
Autonomic: Irregular heartbeats23.87
Physical: Organic Diet23.80
Immune: Viral infections with prolonged recovery periods23.79
Autonomic Manifestations: light-headedness23.75
DePaul University Fatigue Questionnaire : Trouble expressing thoughts23.70
DePaul University Fatigue Questionnaire : Feel unsteady on feet23.61
Official Diagnosis: Mast Cell Dysfunction23.61
Onset: less than 02 years since onset23.60
Neurological: Difficulty reading23.59
Neurological: Difficulty processing information (Understanding)23.57
Immune Manifestations: Inflammation of skin, eyes or joints23.55
Neuroendocrine Manifestations: sweating episodes23.42
Neurological: Executive Decision Making (Difficulty making)23.39
DePaul University Fatigue Questionnaire : Absent-mindedness23.34
General: Heavy feeling in arms and legs23.32
Infection: Epstein-Barr virus23.30
DePaul University Fatigue Questionnaire : Abdomen pain23.29
Neuroendocrine Manifestations: Air Hunger23.25
Pain: Joint pain23.25
Neurological-Sleep: Inability for deep (delta) sleep23.24
Autonomic Manifestations: Orthostatic intolerance23.20
DePaul University Fatigue Questionnaire : Does physical activity make you feel better23.18
Comorbid: Multiple Chemical Sensitivity23.15
Post-exertional malaise: Next-day soreness after everyday activities23.13
Official Diagnosis: Autoimmune Disease23.09
DePaul University Fatigue Questionnaire : Frequently loose train of thought23.09
Immune Manifestations: Mucus in the stool23.08
Condition: Non-Celiac Gluten Sensitivity23.05
DePaul University Fatigue Questionnaire : Difficulty retaining information23.04
DePaul University Fatigue Questionnaire : Slowness of thought23.01
Neurological: Dysautonomia22.95
DePaul University Fatigue Questionnaire : Difficulty reasoning things out22.94
Comorbid-Mouth: TMJ / Dysfunction of the temporomandibular joint syndrome22.93
DePaul University Fatigue Questionnaire : Eye pain22.92
DePaul University Fatigue Questionnaire : Pain in Multiple Joints without Swelling or Redness22.90
Neuroendocrine Manifestations: Painful menstrual periods22.90
Neurological: Myoclonic jerks or seizures22.89
DePaul University Fatigue Questionnaire : Shortness of breath22.88
Autonomic: Ocassional Tachycardia (Rapid heart beat)22.86
Immune Manifestations: recurrent flu-like symptoms22.86
Neurological: Cognitive/Sensory Overload22.84
DePaul University Fatigue Questionnaire : Difficulty following things22.84
Autonomic Manifestations: Postural orthostatic tachycardia syndrome (POTS)22.83
Immune: Chronic Sinusitis22.83
DePaul University Fatigue Questionnaire : Temperature lower than normal22.82
DePaul University Fatigue Questionnaire : Impaired Memory & concentration22.76
Comorbid: Hypothyroidism22.74
DePaul University Fatigue Questionnaire : Hot or Cold spells22.72
Official Diagnosis: Autism22.72
DePaul University Fatigue Questionnaire : Muscle weakness22.68
Neuroendocrine Manifestations: Muscle weakness22.64
Autonomic Manifestations: nausea22.62
Autonomic: Nausea22.59
Age: 30-4022.59
Blood Type: O Positive22.58
DePaul University Fatigue Questionnaire : Mood swings22.58
Sleep: Need to nap daily22.57
Neuroendocrine: Feeling hot or cold for no reason22.53
DePaul University Fatigue Questionnaire : Sensitivity to Alcohol22.52
DePaul University Fatigue Questionnaire : Blurred Vision22.49
Onset: less than 04 years since onset22.47
Physical: Amalgam fillings22.43
Neuroendocrine Manifestations: Paraesthesia (tingling burning of skin)22.42
Post-exertional malaise: Mentally tired after the slightest effort22.40
Neurological-Vision: inability to focus eye/vision22.38
Immune: Recurrent Sore throat22.38
DePaul University Fatigue Questionnaire : Difficulty staying asleep22.37
DePaul University Fatigue Questionnaire : Need to have to focus on one thing at a time22.37
DePaul University Fatigue Questionnaire : Ringing in the Ears22.34
Immune Manifestations: Diarrhea22.26
General: Headaches22.25
Immune Manifestations: Hair loss22.25
DePaul University Fatigue Questionnaire : Difficulty comprehending Information22.24
Neuroendocrine Manifestations: Rapid muscular fatiguability22.24
Post-exertional malaise: Worsening of symptoms after mild mental activity22.24
Physical: Breastfed22.23
Physical: Long term (chronic) stress22.22
DePaul University Fatigue Questionnaire : Headaches22.21
Physical: Steps Per Day 2000-400022.21
Neuroendocrine: Lost or gained weight without trying22.19
Autonomic Manifestations: irritable bowel syndrome22.18
Post-exertional malaise: Physically drained or sick after mild activity22.15
General: Depression22.15
Physical: Pets22.14
Neurological: Joint hypermobility22.12
DePaul University Fatigue Questionnaire : Forgetting what you are trying to say22.10
Neurological-Audio: hypersensitivity to noise22.04
Comorbid: High Anxiety22.02
Immune Manifestations: Inflammation (General)21.97
Age: 50-6021.94
Onset: 2000-201021.89
Immune: Flu-like symptoms21.85
DePaul University Fatigue Questionnaire : Anxiety/tension21.78
Sleep: Waking up early in the morning (e.g. 3 AM)21.76
Post-exertional malaise: Muscle fatigue after mild physical activity21.75
Post-exertional malaise: Physically tired after minimum exercise21.70
Comorbid: Constipation and Diarrohea (not explosions)21.70
DePaul University Fatigue Questionnaire : Muscle Pain (i.e., sensations of pain or aching in your muscles. This does not include weakness or pain in other areas such as joints)21.69
Comorbid-Mouth: Bruxism – Jaw cleanching / Teeth grinding21.65
Condition: Acne21.63
Immune: Sensitivity to smell/food/medication/chemicals21.61
Blood Type: A Positive21.61
Immune Manifestations: Abdominal Pain21.59
Physical: Northern European21.58
Pain: Pain or aching in muscles21.54
Neuroendocrine Manifestations: intolerance of extremes of heat and cold21.52
General: Sinus issues with headaches21.48
Post-exertional malaise: Post-exertional malaise21.48
Post-exertional malaise: Rapid muscular fatigability,21.44
Neuroendocrine: Cold limbs (e.g. arms, legs hands)21.42
Immune Manifestations: Chronic Flatus / Flatulence / gas21.39
DePaul University Fatigue Questionnaire : Allergies21.39
DePaul University Fatigue Questionnaire : Does physical activity make you feel worse21.37
Onset: less than 16 years since onset21.35
Neuroendocrine Manifestations: Dry Eye (Sicca or Sjogren Syndrome)21.35
Neurocognitive: Slowness of thought21.35
Neurological: Word-finding problems21.30
Neurological: Impairment of concentration21.29
Immune Manifestations: new food sensitivities21.28
Post-exertional malaise: Worsening of symptoms after mild physical activity21.27
Physical: Steps Per Day 4000-800021.26
Immune Manifestations: Alcohol Intolerant21.25
Physical: Steps Per Day < 200021.24
Condition: ME/CFS without IBS21.23
DePaul University Fatigue Questionnaire : Need to nap during each day21.23
DePaul University Fatigue Questionnaire : Poor Appetite21.23
DePaul University Fatigue Questionnaire : Fatigue21.21
Physical: Eastern European21.21
Neurocognitive: Can only focus on one thing at a time21.20
Condition: ME/CFS with IBS21.15
Neurocognitive: Problems remembering things21.13
DePaul University Fatigue Questionnaire : Difficulty recalling information21.10
DePaul University Fatigue Questionnaire : Difficulty falling asleep21.08
Sleep: Daytime drowsiness21.07
Neurocognitive: Absent-mindedness or forgetfulness21.07
Post-exertional malaise: Rapid cognitive fatigability,21.05
Onset: Sudden21.03
DePaul University Fatigue Questionnaire : Easily irritated21.03
DePaul University Fatigue Questionnaire : Walking up early in the morning (e.g. 3AM)21.03
Immune Manifestations: medication sensitivities.21.01
Neurological-Audio: Tinnitus (ringing in ear)20.98
Comorbid: Small intestinal bacterial overgrowth (SIBO)20.96
Physical: Work-Sitting20.96
Neuroendocrine: Alcohol intolerance20.91
Neurological-Sleep: Insomnia20.91
Onset: Gradual20.90
Neurocognitive: Difficulty understanding things20.84
Autonomic Manifestations: palpitations20.80
Neurological: Short-term memory issues20.71
DePaul University Fatigue Questionnaire : Post-exertional malaise, feeling worse after doing activities that require either physical or mental exertion20.52
Autonomic: Heart rate increase after standing20.51
Immune Manifestations: Bloating20.51
DePaul University Fatigue Questionnaire : Unrefreshing Sleep, that is waking up feeling tired20.49
DePaul University Fatigue Questionnaire : Difficulty finding the right word20.46
Comorbid: Histamine or Mast Cell issues20.41
Gender: Female20.35
Post-exertional malaise: Inappropriate loss of physical and mental stamina,20.33
Neurocognitive: Difficulty expressing thoughts20.27
Post-exertional malaise: Difficulty reading after mild physical or mental activity20.25
Official Diagnosis: Chronic Fatigue Syndrome (CFS/ME)20.20
Post-exertional malaise: General20.19
Official Diagnosis: COVID19 (Long Hauler)20.18
Official Diagnosis: Allergic Rhinitis (Hay Fever)20.06
Neuroendocrine Manifestations: Poor gut motility20.04
Sleep: Problems staying asleep20.03
Onset: 2010-202020.01
Neuroendocrine Manifestations: worsening of symptoms with stress.19.94
Neurocognitive: Brain Fog19.88
Immune Manifestations: general malaise19.84
Sleep: Problems falling asleep19.75
Neuroendocrine Manifestations: cold extremities19.68
Official Diagnosis: Irritable Bowel Syndrome19.64
Neurocognitive: Difficulty paying attention for a long period of time19.57
Immune Manifestations: Constipation19.42
Age: 20-3019.37
Age: 40-5018.92
Sleep: Unrefreshed sleep18.84
General: Fatigue18.39
Gender: Male18.29

This is part of research in progress and intended to indicate the degree that the microbiome may contribute to various symptoms. The above was based on testing models against this data to determine how often it predicted correctly.

Work is in progress to generate suggestions to moderate the microbiome away from these symptoms.

For a list of the genus for each, see Citizen Science Symptoms To Genus Special Studies. Using 84+%ile for high to be deemed a match, and 16-% for low to be deemed a match has produced good results,

Food/supplements recommendations for increasing serotonin(5-HT)

This was a request from a reader and I will do a direct approach Items reported from studies.

Items from Published Studies

  1. Tryptophan: This is an amino acid that the body converts into serotonin. It’s found in foods like turkey, cheese, and nuts, but it’s also available as a supplement.
  2. 5-HTP (5-Hydroxytryptophan): This is a by-product of tryptophan and is directly converted into serotonin in the body. It’s often used as a supplement for mood enhancement.
  3. St. John’s Wort: Often used for depression, St. John’s Wort is believed to affect serotonin levels, although its exact mechanism is not fully understood.
  4. SAMe (S-adenosylmethionine): This is a compound naturally found in the body that is thought to enhance neurotransmitter production, including serotonin.
    • “Use of SAMe elicited no significant adverse effects beyond placebo, however it was implicated in one case of serotonin syndrome-like symptoms.” [2018]
  5. Omega-3 Fatty Acids: Found in fish oil and certain plant oils, omega-3 fatty acids are linked to improved mental health and mood regulation, possibly through influencing serotonin pathways.
  6. Vitamin B6 and B12: These vitamins are important for serotonin production. A deficiency in these vitamins can lead to reduced serotonin levels.
    • “vitamin B6, a cofactor in the tryptophan-serotonin pathway critical to mood regulation.” [2023]
    • Link between higher levels of homocysteine and depression [2012]
      • “Homocystcinc is reconstituted into methionine, which is essential to the production of neurotransmitters such as serotonin and dopamine which elevate mood. This reconstitution requires B-group vitamins, especially folic acid and B12.Ā “
  7. Magnesium: This mineral plays a role in many biochemical reactions in the body and has been suggested to have a mood-stabilizing effect, possibly by influencing serotonin.
    • Effect of subacute manganese feeding on serotonin metabolism in the rat [1978]
  8. Probiotics: Some research suggests that gut health can impact serotonin levels, as a significant amount of this neurotransmitter is produced in the gut.

Foods

  • Foods with Tryptophan: “chicken, soya beans, cereals, tuna, nuts and bananas’ may serve as an alternative to improve mood and cognition.Ā ‘ [2013]
  • Withania somnifera (Ā ashwagandha)
    • “subjects showed significant increases in serum serotonin, gastrin,” [2024]
  • kiwifruit
    • ”Ā treatments increased urinary concentration of the serotonin metabolite” [2023]
  • poly-γ-glutamic acid with vitamin B6
    • “a greater increase in the group C intervention (4.59 ± 38.5 ng/mL) in serum serotonin concentrations’ [2021]

Vitamin D has no effect (multiple studies)

Technical Note: Applying Studies to Individuals Part I

In this post I will show the results of a series of experiments using the results of prior posts, . The philosophical question being asked is this “How useful is a result showing that genus X mean is higher with a condition then without for screening individuals?” (i.e. with statistical significance of P < 0.01 or better).

Often studies will provide a statement such as the one shown below.

Men with higher VFA harbored a smaller relative abundance of Blautia and Bifidobacterium (P for trend: 0.003 and 0.021, respectively),

Blautia genus associated with visceral fat accumulation in adults 20-76 years of age [2019]

While it is possible to compute the t-score from p < 0.003 [assuming sample size of 100 was used, then 2.871] and then a priori apply it to the mean and standard deviation of population for a specific lab (per million) [mean: 89,844, standard deviation: 60,542] and get a proxy mean for male VFA = mean – 2.871 * StdDev/ 10 => 43,160.

We do not have an answer for the probability of a sample with 50,000 or 20,000 units. We could assume we have a normal distribution but that is an naĆÆve assumption. A normal distribution would have average and median co-located. For some bacteria, the mean is at the 90th percentile.

On my citizen science site, I kludged in some prediction algorithms which has been well received (including by medical practitioners reporting that it often identifies symptoms that the patient forgot to mention). I would like to improve and validate these prediction algorithms using more traditional methods.

This is a bit of a wandering post as I explore various approaches.

To investigate this, I am using a dataset processed through a single process (Biomesight.com) of 2585 samples (the Population). From these 2585 samples, we compute the percentile ranking of the percentage of each taxa. Of these samples, some 1080 (the Sample) have annotated with self-declared symptoms or conditions with 279 different symptoms. We selected only symptoms with more than 36 samples annotated with that symptom. We will work at the genus level only so each variable is conceptually reasonably independent.

With this data, we will try to construct and then test models for the hundred of symptoms sets available.

Foundations

We start with the t-scores we obtained from regression on the count per million of each genus against symptoms [1 below]. There are multiple of other possibilities as shown below. These were initially explored and none showed significant better results than [1] after running 48,000 models.

  1. Based on the average, standard deviation, ratio between with and without symptom of the percentage of the microbiome — ignoring not reported [C]
  2. Based on the average, standard deviation, ratio between with and without symptom of the percentage of the microbiome deeming not reported to be a zero [CN]
  3. Based on the average, standard deviation, ratio between with and without symptom of the percentile over all samples — ignoring not reported [P]
  4. Based on the average , standard deviation, ratio between with and without symptom of the percentile over all samples — deeming not reported to be a zero [PN]
  5. Based on those above or below the Nth percentile between with and without symptom — ignoring not reported [#]
  6. Based on those above or below the Nth percentile between with and without symptom — deeming not reported to be a zero [#N]

Percentiles can be useful because it transforms the data into a uniform continuous distribution and should always be explored with microbiome data. I will return to this in subsequent posts.

T-scores

Each genus to symptom analysis results in a t-score. We will use the following 4 values in our tests.

  • 1.28 (90%)
  • 2.33 (99%)
  • 3.10 (99.9%)
  • 3.73 (99.99%)

In our regression analysis we obtain the following average counts across symptoms. We also factor in prevalence since some significant genus may be rarely seen to determine the expected number of genus that a sample may have reported that matches our regression pattern.

  • t-score: 1.28: average number of genus: 317, with prevalence factored in: 94
  • t-score: 2.22: average number of genus: 294, with prevalence factored in: 85
  • t-score: 3.1: average number of genus: 270, with prevalence factored in: 76
  • t-score: 3.73: average number of genus: 243, with prevalence factored in: 64

Number of Standard Deviations

The process of doing +/- 1 standard deviation will eliminate some significant genus, if the value is below zero or above the population (a nominal 1,000,000) the using it as a test becomes moot.

  • t-score: 1.28: with prevalence factored in: 94;1 std dev is 38 , 2 std dev is 34
  • t-score: 2.22: with prevalence factored in: 85; 1 std dev is 34, 2 std dev is 30
  • t-score: 3.1: with prevalence factored in: 76; 1 std dev is 30, 2 std dev is 26
  • t-score: 3.73:with prevalence factored in: 64; 1 std dev is with 25, 2 std dev is 22

With 1 std dev, the expected number of match per sample is 16% (thus 4 to 5.4). These numbers are on the edge for usability with Pearson’s Chi Square (for discussion see chi-square test of independence rule of thumb: n > 5). Increasing belong one std dev drops the expected value uncomfortably low.

The chart below shows the number of genus to check against and the red line being 16% (the number of matches expected by randomness). We compute the genus by factoring in the prevalence of each genus. Roughly 30% falls below the magic threshold of having an expected mean of 5.

From this list we will take two apparently independent symptoms at the high end to see how they behave:

  • Official Diagnosis: Attention deficit hyperactivity disorder (ADHD) [#264] – with 54 samples and 118 genus
  • Physical: Tonsils removed (TR) [#442] – with 45 samples and 122 genus
  • Brain Fog (BF) [#289] – with 339 samples and 122 genus and 60 genus
SymptomWithout With
ADHD – Average Percentage of Matches to Possible2.311.6
TR – Average Percentage of Matches to Possible5.410.3
BF – Average Percentage of Matches to Possible4.78.4
ADHD – Average number of Matches2.86
TR – Average number of Matches 2.96.4
BF – Average number of Matches 0.71.4
ADHD – Average number of Possible5251
TR – Average number of Possible5259
BF – Average number of Possible1516
ADHD – Average of individual Chi squares5.32.1
TR – Average of individual Chi squares4.43.2
BF- Average of individual Chi squares1.31.6

The numbers above interesting and unexpected. with 50 possible matches and 1 standard deviation, we expect 16% to be matched at random. We observe With being below at 11% and without being in the 2-5% range.

With ADHD we tested to see percentage correct with different percentages as a threshold.

Percentile MatchWithWithout
124872
115290
106187
96281
87277
77772
67964
57957
The optimal Percentile match is 7.5 with 75% correct prediction for both With and WIthout

To clarify this table, we will use percentile match of 5. We correctly identify 79% of people with ADHD that have that condition. We only correctly identify 57% of people that are normal and identify 43% of normal people are identify as having ADHD. So, with 100 people with ADHD and 100 without, we end up with 79+43 = 122 people predicted to have ADHD, of which 64.5% are correctly identify. Since the incidence of ADHD is about 5%, then for a random population we end up with 79 +(20 * 43) with ADHD suggested from the microbiome. This mean that only 8% of those identified as having ADHD based on the microbiome actually has it. This is clearly a weak predictive tool when used alone.

Ah, Dangerous Assumptions!

The 16% of possible tests is based on the assumption that we have independence between genus. This is a naĆÆve and statistically dangerous assumption. Any one that is familiar with the KEGG: Kyoto Encyclopedia of Genes and Genomes knows that bacteria are far from independent. One feeds the next genus and may also produce toxins that inhibits other genus. If you make the small philosophical step that the mixture of compounds and enzymes plays a major role with symptoms then we walk into a world full of different genus sets producing similar mixtures. We are not in a one bacteria causes a condition world.

We cannot safely apply standard statistical models.

What is the bottom line?

The above was done using the following information:

  • A genus or other rank is reported to be statistically significant difference of means. We believe this data may come from a different lab sample processing (assuming reasonableness).
    • We ignore the amount of difference. The amount of difference is very dependent on a lab’s processing.
  • We have the average and standard deviation from the lab that the sample was processed with.
  • Counting those that exceeds the mean +/- 1 standard deviation will likely identify which group that the sample will likely belong to. Above we reached 75% accuracy for both groups if we have a small sample to tune it with.
  • We may need a significant number of genus or other rank. We cannot focus on a few select bacteria.

Identifying the my preferred “sweet point” where the probability is equal for identifying into each group is shown above — but requires a significant number of annotated samples for each groups. There may be another novel way…. that the exploration in my next post.

Using Published Studies

Most published studies use very small sample sizes for both control and condition. A Condition-Taxon listing is available here. The number of potential taxon matches (adjusted for prevalence in Biomesight samples) is below.

Metabolic Syndrome48.9
Mood Disorders46.0
Type 2 Diabetes42.9
Crohn’s Disease40.7
Autism37.7
Depression37.4
Liver Cirrhosis36.8
Long COVID34.3
Ulcerative colitis30.7
Obesity28.6
Schizophrenia26.5
COVID-1925.5
rheumatoid arthritis (RA),Spondyloarthritis (SpA)25.3
Carcinoma22.5
Multiple Sclerosis22.2
Parkinson’s Disease20.7
Inflammatory Bowel Disease20.6
hypertension (High Blood Pressure20.4
Alzheimer’s disease20.1

Which bacteria produces ….

A frequent question is shown below

The process is simple, but partially hidden.

First login and then change display to Advance

A new menu will appear

Click Compounds x ( Producers, Consumers). After a little time the page will appear with search option. There are 18,000 items listed.

Type the item that you are interest into the search field.

In many cases, this may lead to you needing to read more. Common speech names may not match with the scientific name. In this case we have three forms of lactic acids. the (R)-Lactate is the form that the body has trouble clearing and is associated with neurological issues. There can be some effort required to get up to a reasonable understanding.

What do Zero Mean?

Some chemicals will show 0 0 – this means that it is nether produced nor consumed by bacteria in the microbiome. These may be manufactured or consumed by the body’s cell or obtained from food.

Clicking the Red or Green buttons will down load a PDF which lists the bacteria

Followed by Take and Avoid lists

REMEMBER: These are all computed from calculation and not verified by clinical studies.

The numbers takes you to a list

Technical Note: Yield of Applying Different Statistical Methods

Using the five methods described in Technical Note: The Four Winds of Microbiome Analysis, I ran these method on all of the data on the citizen science site of Microbiome Prescription testing for all symptoms that have been self-reported from users of Ombre Labs and Biomesight retail microbiome tests. The data from each lab was done is insolation (you cannot mix data from different processions flows, see The taxonomy nightmare before Christmas… for how the results from the same FASTQ files are reported by 4 different processing flows).

My criteria for deeming a genus significant was:

  • At least one method reported P < 0.01
  • At least two methods reported P < 0.05

The 2 @ P < 0.05 is a bit of shooting from the hip; I expect some correlation between methods but not sufficient to have that adjusted P value to be outside of the range 0.0025 and 0.01. The statistics on significant genus found is below. The 2 @ P < 0.05 produce only a small contributions,

Significant CountP < .01P < .05
231202
24103
504
5557611
1771412
1083513
628014
71115
2866022
436123
1287624
364625
1352333
663634
470035
4950144
900445
2906055

326 Symptoms Had significant Statistical Associations

An example of symptoms with a number of associations is shown below. You may examine them here Citizen Science Symptoms To Genus Special Studies.

There are some great contrasts between these two labs

With the next set being very interesting. I know that there is a significant subset of 0-20 years old autistic children whose parent have done their microbiome and uploaded. This appears to be reflected in the data. It does call into questions the 10-20 yo associations because of the likely over-representation of autism in this range group.

All of this data is freely available at:

Drilling Down to Genus Involved

If on the above page you click on the count, you will be taken to a sortable table showing the genus. In the example below, we look at the most significant (i.e. P < 0.01 for all five methods).

Looking at Lachnobacterium, we see the expected pattern

  • The odds of seeing this genus for people with mast cell issues in slightly elevated (1.037)
  • The percentage seen is 3.2x what the average for others are
  • The percentile is about 1.19x higher

Looking at Lactococcus we see a more confusing picture

  • The genus is seen less often (0.928)
  • The amount seen with this genus is found is actually much higher (2.057)
  • The percentile ranking is slightly lower (0.943)

Both Percentage and Percentile numbers are the maximum using paired and unpaired statistics which may partially account for an apparent contradiction.

Bottom Line

The purpose of this post was to illustrate the data produced from using the five different ways of finding statistically significant association of genus to symptoms. For many readers, this data may be difficult to accept because it disagree with the common sense view of the microbiome that they are working with.

For example, if a genus is seen more often, then you would expect the average amount to be higher. This is often false looking at real data. Understanding the microbiome means discarding simple mechanical models and understanding a complex world of interactions with cascading consequences.

Note: Why we have so many association… Sample Size!

For each of these analysis we have over 1000 annotated samples. As sample size increases, the ability to detect significance goes up significantly.

Pending Work

Tuning parameters:

The numbers will be changing as I tune thresholds. At present:

  • I raised the number of times that a genus need to be reported in annotated samples to 36 (i.e. around 0.3% prevelance)
  • Number of cases with symptoms reported to 30

This reduced the volume of results (we are not saying less significance — we are filtering by rarer occurrence).

The next step is applying this to an individual microbiome result for a person with one or more symptoms. This means determining which bacteria are the greatest probable contributors and the weight to be given to each for determining a course of microbiome modification.